About Us
Nanophysics & Beyond
Curadigm
The Management
Healthcare Professionals
Scientific Publications
Patients
Patient Engagement
Investors
Corporate Presentation
Financial Calendar
Regulated Information
SEC Filings
Annual General Meetings
Shareholder Corner
Press Releases
Congresses & Events
Nanotalks
NBTXR3 Development
Our Expert Videos
Nanoblog
From Curie to Nano
Contact & Newsletter
Medical Device Vigilance – Pharmacovigilance
Medical Information
Join Us
Nous vous informons que ce site est conforme à la législation française actuelle sur les dispositifs médicaux.
Continuer
Rester sur la page
Financial | Nanobiotix revenue for the 1st quarter of 2017
Financial | Nanobiotix: 2016 Annual Results
28 April 2017
Scientific Clinical | NANOBIOTIX announces first positive Human data showing that NBTXR3 could become a backbone in Immuno-Oncology
18 May 2017
Financial | Nanobiotix revenue for the 1st quarter of 2017
Published by
Candice Teo
on
15 May 2017
Download pdf
No translations available for this page
